Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015-2023.
Holt F. et al, (2024), Clin Oncol (R Coll Radiol), 36, e322 - e332
Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.
Jones DA. et al, (2023), Clin Oncol (R Coll Radiol), 35, 301 - 310
Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
Ntentas G. et al, (2022), Int J Radiat Oncol Biol Phys, 112, 913 - 925
Informing Radiotherapy Decisions in Stage I/IIa Hodgkin Lymphoma: Modelling Life Expectancy Using Radiation Dosimetry.
Jones DA. et al, (2021), Blood Adv
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.
Cutter DJ. et al, (2021), J Clin Oncol, 39, 3591 - 3601
Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.
Duane FK. et al, (2021), Radiother Oncol, 164, 261 - 267
The role of motion management and position verification in lymphoma radiotherapy.
Aznar M. et al, (2021), The British journal of radiology, 94
Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction.
Ntentas G. et al, (2020), Radiother Oncol, 153, 155 - 162
Cardiac Radiation Dose Reconstruction in the Study of Late Effects: A Comparison of Different Methods
Ntentas G. et al, (2018), RADIOTHERAPY AND ONCOLOGY, 127, S1091 - S1092